Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.

Not Applicable

Active, not recruiting

• Conditions: Blood Cancer; Bone Marrow Transplant (BMT)

• Registration Number: NCT06645132
• Lead Sponsor: Medical College of Wisconsin

Brief Summary

The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-transplant inpatient hospital stay to promote physical recovery and well-being.

Detailed Description

Enrolled patients who have been diagnosed with a hematologic malignancy and are scheduled to undergo an allogeneic bone marrow transplant will use a custom-designed wearable device and smartphone application as a behavioral intervention to cue exercise. Participants will be asked to wear the wearable device for the duration of their post-transplant inpatient hospital stay.

Aim 1. To examine the potential efficacy of the wearable device + smartphone application to prompt alloBMT patients to move.

Aim 2. To receive participant feedback on their experience participating in the study.

Study Timeline

• Study First Submitted: 2024-10-14
• Study First Submitted QC: 2024-10-15
• Study First Posted: 2024-10-16
• Study Start: 2024-10-28
• Status Verified: 2024-11
• Primary Completion: 2025-01-21
• Last Update Submitted: 2025-02-13
• Last Update Posted: 2025-02-14
• Study Completion: 2025-09

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• At least 18 years of age
• Diagnosed with hematologic malignancy
• Scheduled to receive an alloBMT
• Physician consent to participate in the study

Exclusion Criteria

• Inability to complete 15 minutes walking unassisted

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Pilot evaluation of intervention efficacy	cumulative percent from day 1 through discharge from hospital, on average day 30	Efficacy will be evaluated by examining the percentage of time participants responded to the cued exercise prompts.
Patient feedback from participation in the study	day 10	Patient experience will be evaluated by looking at the central tendencies of the ratings from the post-participation evaluation survey.

Trial Locations

Locations (1)

Froedtert Hospital; 🇺🇸 Milwaukee, Wisconsin, United States